Viemed Healthcare Announces Principal Physician Researcher to Present Latest Clinical Findings Medical Device Investing
Merck Announces Receipt of Antitrust Clearance in Germany and Austria Relating to Tender Offer to Acquire Acceleron Pharma Inc. Life Science Investing
First And Only Randomized, Double-blind, Head-to-head Study Comparing Aimovig® , An Anti-CGRP Pathway Therapy, To Topiramate Published In Cephalalgia Market News
Levitee Labs Publishes First Combined Revenue Figures for September 2021 and October 2021 Psychedelics Investing
Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the AAO 2021 Annual Meeting Pharmaceutical Investing
Medtronic announces 2045 net zero emissions ambition to combat climate change Medical Device Investing
Sixth Wave Announces Addition of Honorable Grant Mitchell to the Board of Directors Medical Device Investing
Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 for the Treatment of Spinocerebellar Ataxia Psychedelics Investing
Levitee Labs Signs LOI to Acquire Controlling Interest in a R&D Compounding Pharmacy; Focus to be on Levitee-Branded Products Psychedelics Investing
COMPASS Pathways plc to announce third quarter 2021 financial results on 9 November 2021 Psychedelics Investing
Neoadjuvant Opdivo Plus Chemotherapy Significantly Improves Event-Free Survival in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial Pharmaceutical Investing
